Dermatomyositis Clinical Trials

124 clinical trials for Dermatomyositis across international registries, including 35 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• FAST for DM - Fatty Acid Supplementation Trial (FAST) for Dermatomyositis (DM) — RECRUITING · PHASE2
• Adult and Juvenile Myositis — RECRUITING
• Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO — RECRUITING · PHASE1
• RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy — RECRUITING · PHASE2
• Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial) — RECRUITING · PHASE1
• A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Active Idiopathic Inflammatory Myopathy — RECRUITING · PHASE3
• Subcutaneous Injection of Sodium Thiosulfate for Ectopic Calcifications or Ossifications. A Pilot Study — RECRUITING · PHASE2
• Phase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial) — RECRUITING · PHASE1
• Identification of Cutaneous and Blood Biomarkers Predictive of Response to Systemic Treatments During Chronic Inflammatory Skin Diseases — RECRUITING
• Environmental Risk Factors for the Anti-synthetase Syndrome — RECRUITING
• Baricitinib in Patients With Relapsing or naïve Dermatomyositis — RECRUITING · PHASE3
• A Study to Understand How the Study Medicine Dazukibart Works in People With Idiopathic Inflammatory Myopathies — RECRUITING · PHASE3
• Intralesional Injection of STS in Treatment of Calcinosis — RECRUITING · PHASE2
• Exploratory Clinical Study of Anti-CD19/BCMA Universal CAR-T Cell Injection for the Treatment of Refractory Autoimmune Diseases — RECRUITING · NA
• Clinical Responsiveness of Dermatomyositis Using Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI) — RECRUITING
• Rheumatology Patient Registry and Biorepository — RECRUITING
• A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101 — RECRUITING
• RCT of Tocilizumab for Anti-MDA5+DM — RECRUITING · NA
• MIHRA - Patient-Rooted Insights for Shaping Myositis Science (PRISMS) — RECRUITING
• Panniculitis in Dermatomyositis — RECRUITING
• Severity Factors of Dermatomyositis in the Caribbean Population - DM-ANTILLES — RECRUITING
• Topical Ruxolitinib Cream for Refractory Cutaneous Dermatomyositis — RECRUITING · PHASE2
• CAR-T Cells in Systemic B Cell Mediated Autoimmune Disease — RECRUITING · PHASE1
• Photoacoustic/Ultrasound Imaging in Patients of Dermatomyositis With Calcinosis Cutis: Characteristic Findings and Treatment Response Evaluation — RECRUITING · NA
• Study of KYV-101 Anti-CD19 CAR T Therapy in Adult Dermatomyositis — RECRUITING · PHASE1
• Anti-CD19 CAR T-Cell Therapy in Refractory Systemic Autoimmune Diseases — RECRUITING · PHASE1
• Home Based Clinical Management of Interstitial Lung Disease in Systemic Rheumatic Diseases — RECRUITING · NA
• Clinical Study of CD19 Targeted Universal Chimeric Antigen Receptor T Lymphocytes (UCAR-T) for the Treatment of Refractory Juvenile Dermatomyositis (RJDM) — RECRUITING · PHASE1
• Evaluation of Severity in Juvenile and Adult-onset Dermatomyositis — RECRUITING
• Neutrophil Extracellular Traps in Different Forms of Systemic Sclerosis — RECRUITING
• 3T Therapy in the Treatment of MDA5-positive Dermatomyositis — RECRUITING · PHASE4
• Safety and Efficacy of CD19 Targeted CAR-T Therapy for Refractory Autoimmune Disease — RECRUITING · PHASE1
• Interleukin-2 on Active Dermatomyositis — RECRUITING · PHASE3
• A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 TRIAL TO EVALUATE EFFICACY AND SAFETY OF LENABASUM IN DERMATOMYOSITIS — RECRUITING · PHASE3
• PROSPECTIVE, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED PHASE III STUDY EVALUATING EFFICACY AND SAFETY OF OCTAGAM 10% IN PATIENTS WITH DERMATOMYOSITIS ("PRODERM STUDY") — RECRUITING · PHASE3
• Studies of the Natural History and Pathogenesis of Autoimmune/Connective Tissue Diseases — COMPLETED
• Environmental Risk Factors for Myositis in Military Personnel — COMPLETED
• BAFF CAR-T Cells (LMY-922) for Treatment of Refractory Autoimmune Disease — NOT_YET_RECRUITING · PHASE1
• A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathy. — COMPLETED · PHASE2
• A Study to Investigate the Efficacy and Safety of Brepocitinib in Adults With Dermatomyositis — ACTIVE_NOT_RECRUITING · PHASE3
• Emapalumab MDA5 Rapidly Progressive Interstitial Lung Disease (RP-ILD) Study — NOT_YET_RECRUITING · PHASE2
• Teams Engaged in Accessible Mental Health Interventions for Lupus Erythematosus and Dermatomyositis Stress — NOT_YET_RECRUITING · NA
• A Study Evaluating the Effects of GLPG3667 Given as Oral Treatment for up to 24 Weeks in Adults With Dermatomyositis — COMPLETED · PHASE2
• Biomarkers of Cancer-Associated Myositis — ACTIVE_NOT_RECRUITING
• Construction of a Clinico-Imaging Collaborative Diagnostic Model for Dermatomyositis Combined With Interstitial Lung Disease Based on PET/CT Imaging Features and Clinical Parameters — ACTIVE_NOT_RECRUITING
• Diagnostic Accuracy of Whole Body Magnetic Resonance Imaging in Inflammatory Myopathies — COMPLETED · NA
• Muscle Function and Effects of Repetitive Task Training in Patients With Inflammatory Myopaties — COMPLETED · NA
• Add-on Intravenous Immunoglobulins in Early Myositis — ACTIVE_NOT_RECRUITING · PHASE2
• Efficacy of an Individual Rehabilitation Program in Polymyositis and Dermatomyositis — COMPLETED · PHASE2
• A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of IgPro20 in Adults With Dermatomyositis (DM) — TERMINATED · PHASE3

Refine this search